Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-023309·Aptevo Therapeutics Inc.
Schedule 13G ownership disclosure
Aptevo Therapeutics Inc (US) OLD
Common stock, par value $0.001 per share · CUSIP: 03835L405
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ayrton Capital LLC
Shares: 358,150.00 · Class: 10.0%
- Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Shares: 358,150.00 · Class: 10.0%
- Waqas Khatri
Shares: 358,150.00 · Class: 10.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-023309
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership